SmarTrend identified a Downtrend for Incyte Corp (NASDAQ:INCY) on March 19th, 2018 at $87.42. In approximately 3 weeks, Incyte Corp has returned 25.38% as of today's recent price of $65.23. Incyte Corp share prices have moved …
The stock traded near 60 three years ago ... Analysts had expected Merck and …
Incyte Corporation (INCY) traded on unusually high volume on Apr. 09, as the stock gained 2.09% to close at $65.36. On the day, Incyte Corporation saw 7.9 million shares trade hands on 57,591 trades. Considering that the stock averages …
The stock’s 52-week high is $10.60. Volume totaled around 7.5 million, about double the daily average. The company had no specific news.. Incyte Corp. (NASDAQ: …
Following the news, Incyte’s stock fell by more than 20%; NewLink saw its stock price tumble by roughly 45%. Incyte CEO Hervé Hoppenot acknowledged that the disappointing result “has a negative impact on the probability of success” …
Incyte gapped open sharply lower Friday, but traded in a range for the bulk of the session. The stock closed down by 19.05 at $64.02 on the highest volume of the year. Incyte plunged to a new low for the year.
The biotech sector was on a bumpy ride over the week. Let's take a look at some of the biggest news in the space this past week. These early data suggest that poziotinib may have a meaningful impact on outcomes for patients who have …
Here are some of the companies with shares expected to trade actively in Friday’s session. Stock movements reflect premarket trading. Incyte—Down 21%: The biopharmaceutical company said it was ending a study with & Co. that …
The stock’s 52-week high is $20.47. Volume totaled nearly 14 million, about 20 times the daily average. The company’s future is getting a close look after this morning’s failed trial announcement from Incyte. The Williams Companies Inc. …
Incyte has gapped open sharply lower this morning and is now down 18.37 at $64.69 on strong volume. The stock has tumbled to a new low for the year.